Evidence map›Paper›PMID 35962766›Full record

ArticleThe American journal on addictions2022

Tobacco/nicotine use among individuals using cannabis for therapeutic purposes.

Marc L Steinberg, Rachel L Rosen, Benjamin Billingsley, Drashya Shah, Michele Bender, Kyra Shargo, Affan Aamir, Mary Barna Bridgeman

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in The American journal on addictions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Marc L SteinbergDepartment of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.ORCID 0000-0001-8180-8682
Rachel L RosenDepartment of Psychology, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Benjamin BillingsleyDepartment of Psychology, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Drashya ShahDepartment of Psychology, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Michele BenderRutgers, Ernest Mario School of Pharmacy, The State University of New Jersey, Piscataway, New Jersey, USA.
Kyra ShargoDepartment of Psychiatry, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
Affan AamirDepartment of Psychology, Rutgers, The State University of New Jersey, Piscataway, New Jersey, USA.
Mary Barna BridgemanRutgers, Ernest Mario School of Pharmacy, The State University of New Jersey, Piscataway, New Jersey, USA.
Rutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesWhile the relationship between recreational cannabis and nicotine use is well established, little is known about nicotine use among users of cannabis for therapeutic purposes (CTP).

methodsPatients attending a medical marijuana dispensary (N = 697; 75.3% White; 60.0% male) completed a survey examining nicotine use, motivation to quit cigarette smoking, routes of administration of nicotine and cannabis, and CTP qualifying conditions.

resultsMore than one-third (39.3%) of participants reported current nicotine use. Compared to exclusive cigarette smokers, e-cigarette users and non-users of nicotine were approximately four times more likely to vape, rather than to smoke, cannabis. Furthermore, 46.8% of cigarette smokers reported plans to quit smoking in the next 6 months (but not in the next month) and an additional 31.6% planned to quit in the next month. Having a psychiatric condition was associated with nicotine use and higher motivation to quit smoking. DISCUSSION AND

conclusionsUsers of CTP are more likely to use nicotine products than the general population and the route of administration of nicotine products is related to the route of administration of CTP. If aerosolized CTP is a less harmful route of administration than smoked CTP, dispensary staff should be aware of this relationship and take this into account when recommending a noncombustible route. SCIENTIFIC SIGNIFICANCE: This study further characterizes nicotine use behaviors and motivation to quit smoking among users of CTP and may be among the first to examine nicotine use among patients of a medical marijuana dispensary.

Indexed as

CannabisElectronic Nicotine Delivery SystemsHallucinogensMedical MarijuanaSmoking CessationTobacco ProductsFemaleHumansMaleNicotineHallucinogensMedical MarijuanaNicotine

Identifiers

PMID35962766
OpenAlexW4291228457

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.